Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083809993> ?p ?o ?g. }
- W2083809993 endingPage "371" @default.
- W2083809993 startingPage "363" @default.
- W2083809993 abstract "Recent reports have shown that the AR is the key determinant of the molecular changes required for driving prostate cancer cells from an androgen-dependent to an androgen-independent or androgen depletion-independent (ADI) state. Several recent publications suggest that down-regulation of AR expression should therefore be considered the principal strategy for the treatment of ADI prostate cancer. However, no valid data is available about how androgen-dependent prostate cancer cells respond to apoptosis-inducing drugs after knocking down AR expression and whether prostate cancer cells escape apoptosis after inhibition of AR expression. This review will focus on mechanisms of prostate cancer cell survival after inhibition of AR activity mediated either by androgen depletion or by targeting the expression of AR by siRNA. We have shown that knocking down AR expression by siRNA induced PI3K-independent activation of Akt, which was mediated by calcium/calmodulin-dependent kinase II (CaMKII). We also showed that the expression of CaMKII genes is under AR control: active AR in the presence of androgens inhibits CaMKII gene expression whereas inhibition of AR activity results in an elevated level of kinase activity and in enhanced expression of CaMKII genes. This in turn activates the anti-apoptotic PI3K/Akt pathways. CaMKII also express anti-apoptotic activity that is independent from the Akt pathway. This may therefore be an important mechanism by which prostate cancer cells escape apoptosis after androgen depletion or knocking down AR expression. In addition, we have found that there is another way to escape cell death after AR inhibition: DNA damaging agents cannot fully activate p53 in the absence of AR and as a result p53 down stream targets, for example, microRNA-34, cannot be activated and induce apoptosis. This implies that there may be a need for re-evaluation of the therapeutic approaches to human prostate cancer. J. Cell. Biochem. 106: 363–371, 2009. © 2008 Wiley-Liss, Inc." @default.
- W2083809993 created "2016-06-24" @default.
- W2083809993 creator A5013326292 @default.
- W2083809993 creator A5045503018 @default.
- W2083809993 date "2009-02-15" @default.
- W2083809993 modified "2023-09-26" @default.
- W2083809993 title "Mechanisms of prostate cancer cell survival after inhibition of AR expression" @default.
- W2083809993 cites W1512072225 @default.
- W2083809993 cites W1577630176 @default.
- W2083809993 cites W1650797637 @default.
- W2083809993 cites W1746080159 @default.
- W2083809993 cites W186572914 @default.
- W2083809993 cites W1963691340 @default.
- W2083809993 cites W1966334119 @default.
- W2083809993 cites W1966711011 @default.
- W2083809993 cites W1967275220 @default.
- W2083809993 cites W1970329931 @default.
- W2083809993 cites W1974190379 @default.
- W2083809993 cites W1975437957 @default.
- W2083809993 cites W1976873804 @default.
- W2083809993 cites W1980017984 @default.
- W2083809993 cites W1993711846 @default.
- W2083809993 cites W1997879915 @default.
- W2083809993 cites W2000586986 @default.
- W2083809993 cites W2002408013 @default.
- W2083809993 cites W2002555521 @default.
- W2083809993 cites W2003955264 @default.
- W2083809993 cites W2014385820 @default.
- W2083809993 cites W2015998205 @default.
- W2083809993 cites W2025288244 @default.
- W2083809993 cites W2027239007 @default.
- W2083809993 cites W2029431569 @default.
- W2083809993 cites W2030123475 @default.
- W2083809993 cites W2038167014 @default.
- W2083809993 cites W2039407113 @default.
- W2083809993 cites W2039484278 @default.
- W2083809993 cites W2041409545 @default.
- W2083809993 cites W2043310375 @default.
- W2083809993 cites W2047262284 @default.
- W2083809993 cites W2048603557 @default.
- W2083809993 cites W2049481073 @default.
- W2083809993 cites W2051663161 @default.
- W2083809993 cites W2053538686 @default.
- W2083809993 cites W2059848983 @default.
- W2083809993 cites W2065566217 @default.
- W2083809993 cites W2075637276 @default.
- W2083809993 cites W2077299228 @default.
- W2083809993 cites W2077709632 @default.
- W2083809993 cites W2084647824 @default.
- W2083809993 cites W2085847636 @default.
- W2083809993 cites W2089001345 @default.
- W2083809993 cites W2091550469 @default.
- W2083809993 cites W2093557716 @default.
- W2083809993 cites W2094078784 @default.
- W2083809993 cites W2100273455 @default.
- W2083809993 cites W2103002807 @default.
- W2083809993 cites W2112690088 @default.
- W2083809993 cites W2119337308 @default.
- W2083809993 cites W2122785662 @default.
- W2083809993 cites W2126426563 @default.
- W2083809993 cites W2132424867 @default.
- W2083809993 cites W2134205510 @default.
- W2083809993 cites W2138155367 @default.
- W2083809993 cites W2144154026 @default.
- W2083809993 cites W2144941480 @default.
- W2083809993 cites W2146882135 @default.
- W2083809993 cites W2150775704 @default.
- W2083809993 cites W2152580800 @default.
- W2083809993 cites W2155783912 @default.
- W2083809993 cites W2156483686 @default.
- W2083809993 cites W2319919892 @default.
- W2083809993 cites W2325060315 @default.
- W2083809993 cites W2330709458 @default.
- W2083809993 cites W70351726 @default.
- W2083809993 doi "https://doi.org/10.1002/jcb.22022" @default.
- W2083809993 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19115258" @default.
- W2083809993 hasPublicationYear "2009" @default.
- W2083809993 type Work @default.
- W2083809993 sameAs 2083809993 @default.
- W2083809993 citedByCount "52" @default.
- W2083809993 countsByYear W20838099932012 @default.
- W2083809993 countsByYear W20838099932013 @default.
- W2083809993 countsByYear W20838099932014 @default.
- W2083809993 countsByYear W20838099932015 @default.
- W2083809993 countsByYear W20838099932016 @default.
- W2083809993 countsByYear W20838099932017 @default.
- W2083809993 countsByYear W20838099932018 @default.
- W2083809993 countsByYear W20838099932020 @default.
- W2083809993 countsByYear W20838099932021 @default.
- W2083809993 countsByYear W20838099932022 @default.
- W2083809993 crossrefType "journal-article" @default.
- W2083809993 hasAuthorship W2083809993A5013326292 @default.
- W2083809993 hasAuthorship W2083809993A5045503018 @default.
- W2083809993 hasConcept C121608353 @default.
- W2083809993 hasConcept C126322002 @default.
- W2083809993 hasConcept C134018914 @default.
- W2083809993 hasConcept C184235292 @default.
- W2083809993 hasConcept C185592680 @default.